Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,530 | -27,319 | -18,869 | -13,526 | -5,247 |
| Depreciation Amortization | 174 | 741 | 595 | 457 | 250 |
| Accounts receivable | 43 | 17 | 13 | 27 | -24 |
| Other Working Capital | 4,202 | -1,866 | -3,714 | -1,064 | -2,714 |
| Other Operating Activity | 2,029 | 5,772 | 4,366 | 3,267 | 1,878 |
| Operating Cash Flow | $-4,082 | $-22,655 | $-17,609 | $-10,839 | $-5,857 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,502 | -860 | -156 | -84 | -74 |
| Investing Cash Flow | $-3,502 | $-860 | $-156 | $-84 | $-74 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,829 | 92,403 | 5,145 | 85 | 1 |
| Financing Cash Flow | $1,829 | $92,403 | $5,145 | $85 | $1 |
| Beginning Cash Position | 138,030 | 69,142 | 69,142 | 69,142 | 69,142 |
| End Cash Position | 132,275 | 138,030 | 56,522 | 58,304 | 63,212 |
| Net Cash Flow | $-5,755 | $68,888 | $-12,620 | $-10,838 | $-5,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,082 | -22,655 | -17,609 | -10,839 | -5,857 |
| Capital Expenditure | -3,502 | -860 | -156 | -84 | -74 |
| Free Cash Flow | -7,584 | -23,515 | -17,765 | -10,923 | -5,931 |